Medtronic (MDT) shares reached a session high on Friday amid hopes of expanded reimbursement for renal denervation, a hypertension therapy used in the company’s Symplicity Spyral Renal Denervation ...

Renal denervation received a much-needed shot in the arm after favorable data on the procedures for uncontrolled hypertension were released at the recent Transcatheter Cardiovascular Therapeutics ...

The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

Medtronic scored a huge win for Symplicity Spyral, its renal denervation therapy,y thanks to the Centers for Medicare & Medicaid Services. The agency provided its proposed National Coverage Decision ...

Renal denervation modestly lowers blood pressure, with durable long-term benefits, according to Deepak L. Bhatt, MD, MPH, MBA. Revisit parts 1 and 2 of the interview to learn more about how renal ...

Please provide your email address to receive an email when new articles are posted on . Renal denervation therapy is associated with a sustained reduction in BP out to 3 years as well as an ...

Please provide your email address to receive an email when new articles are posted on . Data show renal denervation safely lowers BP, but some question the durability of effect. Experts continue to ...

There should be no more excuses to the adoption of renal denervation (RDN) as a treatment for hypertension given the recent approval by the U.S. FDA of two technologies and a range of guidelines ...